Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD-Reference-Cited by-同舟云学术

Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD

Published:2024-03 Issue:3 Volume:5 Page:101445
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Liu Zezhong,Zhou Jie,Wang Weijie,Zhang Guangxu,Xing Lixiao,Zhang Keqiang,Wang Yuanzhou,Xu Wei,Wang Qian,Man Qiuhong,Wang Qiao,Ying Tianlei,Zhu Yun,Jiang Shibo,Lu Lu

Funder

Science and Technology Commission of Shanghai Municipality

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference34 articles.

1. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron;Carreño;Nature,2022

2. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies;Cao;Nature,2022

3. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2023

4. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster;Kurhade;Nat. Med.,2023

5. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB;Uraki;Lancet Infect. Dis.,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants;2024-09-05

2. Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants;Cell Reports;2024-08

3. Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection;2024-06-07

4. Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion;2024-05-21

5. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion;mBio;2024-05-08